Clinical Trial Update: Cholecalciferol Supplementation on Disease Activity, Fatigue and Bone Mass on Juvenile Systemic Lupus Erythematosus. [NA]

View source ↗

Summary

A completed juvenile SLE trial evaluated whether cholecalciferol (vitamin D3) supplementation affects disease activity, fatigue, and bone mass.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• Cholecalciferol (Vitamin D3)

Snippet

Sponsor: ROSA MARIA RODRIGUES PEREIRA | Conditions: Systemic Lupus Erythematosus | NA | Status: COMPLETED